FDA's View On Generic Drug Label Carve-Outs
The Camptosar decision clarifies questions surrounding whether and to what extent a generic-drug applicant must match each of the pioneer drug's labeled uses or whether certain uses of the pioneer drug...To view the full article, register now.
Already a subscriber? Click here to view full article